Answers - Insurance

Most people do not know they can sell an insurance policy. There are companies that will pay you more than the cash value. Even term insurance, which has no cash value, is a candidate for purchase.

This tr

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ansaction is called a life settlement. Life settlements have been on the scene since 1995; they are not new. While the purchase is facilitated by an insurance company, the buyers typically are pension and i

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

stitutional funds which hold the policies in their investment portfolios.

Here are three common reasons why a person would sell their insurance policy…

1. The policy has outlived its usefulness.
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

trong>

78% of all insurance is purchased for family protection. Families with children insure the breadwinner(s) until they have had the time to build up an estate or an adequate 401(k) plan to provide for
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
the family, pay off a mortgage and educate the children. Most people have been there and done that.

However, later in life these needs may have disappeared. The house is paid for, the kids have been to co
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro
lege and your 401(k) plan has a balance ten times greater than your life insurance face value.

Rather than continue to pay premiums, or surrender it for its cash value, you can sell it for more than the ca
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
h value. Buy a boat, take an extended vacation or go down to the dealership and plunk down cash for that car you have always wanted.

2. The policy has a large loan.

There are three common
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ways a policy can acquire a large loan.

First, at some point you simply took a maximum loan against your policy. It could have been to satisfy an emergency, take advantage of an investment opportunity—any
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
number of things. But the loan was never repaid.

Second, you could have taken a modest loan years ago and never paid anything toward the principal. Every year, however, you received a bill for the interest
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
due. If you are like many people, this goes in the round file and you never pay the interest. What happens is that the interest gets added to the loan. So what is originally simple interest turns into compo
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
nd interest.

Over time, the loan and the unpaid interest can consume the entire cash value. That's when you get the letter from the insurance company telling you that to keep the policy in force, you need
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a
to come up with some astronomical amount of money.

But that's not the worst of it. When you call your agent to see what your other options might be, he or she informs you that if the policy lapses, there w
dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod
ll be a gain (cash value less premiums paid) that the insurance company is required to report to the IRS. Worse yet is the fact that there is no money in the insurance policy to pay the tax (remember it lap
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ed for lack of premium payment and/or lack of any remaining values). So you are going to have to come up with the tax from someplace else. I don't think you would consider getting this information one of yo
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ur better days.

3. You own Universal Life and interest rates have declined.

Getting this news is another bad day at the mail box. This time the letter from the insurance company says that
t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
in order to keep the policy in force, you have to come up with more than you could get for your first born.

How this occurs goes back to when you bought your policy. One of the major factors in determining
ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust
the premium for a given face amount of Universal Life is the interest rate assumption made in the original proposal. Remember the double-digit interest rates? You could have bought your policy during this t
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ime frame. Most insurance agents would have suggested using a lower interest rate assumption to be conservative. However, interest rates have declined to even below these play-it-safe assumptions.

The sale
.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
of your insurance policy averts all three of these problems. In the first case, you don't have to pay any more premiums for coverage that is no longer needed. In the second, the problem you have with the lo
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip
n disappears and is replaced by cash. And in the third, the probable lapse of the policy due to the fact that the premium to maintain the coverage is off the charts is offset by the cash received via a sale

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

Tags

Links

Answers - How to Sell Your Life Insurance Policy for More Than the Cash Value

Related Articles: